Search

Search Constraints

You searched for: Author/Creator Pestrin, Marta

Search Results

2. Heterogeneity of PIK3CA mutational status at the single cell level in circulating tumor cells from metastatic breast cancer patients. Issue 4 (9th December 2014)

3. Optimizing CDK4/6 inhibitors in advanced HR+/HER2- breast cancer: A personalized approach. (December 2022)

4. Prognostic role of serum thymidine kinase 1 activity in patients with hormone receptor–positive metastatic breast cancer: Analysis of the randomised phase III Evaluation of Faslodex versus Exemestane Clinical Trial (EFECT). (June 2019)